|
Market Closed -
Euronext Paris
11:55:00 2026-09-04 EDT
|
5-day change | 1st Jan Change | ||
| 4.060 EUR | -1.22% |
|
+1.50% | +2.92% |
| 09-03 | Treatment period completed for Inventiva's NATiV3 study |  |
| 09-02 | Inventiva Says All Patients Completed 72-Week Treatment Period in Phase 3 Liver Disease Study | MT |
Main competitors
| Change | 5-day change | 1-month change | 3-month change | YTD change | 1-year change | 3-year change | 5-year change | 10-year change | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
 | -1.22% | +1.50% | +4.77% | +16.00% | +2.92% | -9.07% | +12.78% | -64.26% | - | 1.11B | |
| -1.79% | -2.27% | +4.29% | +59.31% | +69.72% | +43.23% | +88.96% | +15.06% | - | 67.98B | |
| -2.06% | -0.18% | +19.37% | +16.66% | +24.67% | +39.67% | +86.44% | +202.92% | +6,273.75% | 64.94B | |
| -0.31% | +6.54% | +27.54% | +34.04% | -27.44% | -12.96% | +378.92% | +342.97% | +848.12% | 27.58B | |
| +0.86% | +1.65% | +12.56% | +17.80% | +8.99% | -7.74% | -14.95% | -68.96% | - | 26.06B | |
| -3.00% | -2.90% | +21.07% | +50.21% | +56.42% | +33.13% | +12.54% | -57.53% | - | 25.74B | |
| -1.46% | +0.42% | +14.43% | +36.72% | +6.81% | +23.61% | -18.61% | -29.29% | +105.21% | 20.09B | |
| -2.96% | -15.21% | -1.87% | +55.09% | +209.18% | +216.20% | +368.10% | +1,672.10% | +901.62% | 17.16B | |
| -1.49% | -4.88% | -0.49% | +24.40% | +24.78% | -6.60% | +531.89% | - | - | 14.92B | |
| -0.20% | +8.37% | +4.07% | +11.97% | +34.63% | +55.78% | +164.98% | +198.48% | +411.35% | 14.62B | |
| +2.77% | +28.22% | +30.12% | +19.19% | +0.66% | -32.24% | +1,021.34% | +139.20% | +164.74% | 14.04B | |
| -0.28% | +1.37% | +5.24% | +11.11% | -7.09% | +24.99% | +193.27% | +569.99% | +4,458.38% | 12.5B | |
| -0.17% | +1.68% | -0.66% | +18.13% | +30.05% | +196.96% | +208.03% | +27.82% | +1,107.55% | 12.2B | |
| +11.45% | +6.14% | +5.97% | +8.12% | -10.44% | -34.58% | +193.33% | +137.56% | - | 11.89B | |
| -1.66% | +0.87% | -7.77% | +1.73% | +14.45% | +37.18% | +106.83% | +124.03% | +601.93% | 10.11B | |
| -0.02% | +2.21% | +9.37% | +29.14% | +32.55% | +85.22% | +19.92% | +138.35% | - | 9.1B | |
| -1.48% | -4.53% | -3.09% | +13.48% | +11.11% | -13.47% | +135.29% | -22.25% | - | 8.67B | |
| -1.34% | +0.37% | +11.45% | +16.76% | +308.08% | +236.67% | +453.42% | -26.21% | - | 8.56B | |
| +1.98% | -1.53% | -14.73% | +20.81% | +171.61% | +423.41% | +497.28% | -51.90% | -43.05% | 7.85B | |
| +13.16% | +27.61% | +22.15% | +35.06% | +21.04% | +194.51% | +454.76% | - | - | 7.8B | |
| Average | +0.54% | +3.31% | +8.19% | +24.79% | +49.14% | +74.70% | +244.73% | +180.45% | +1,482.96% | 19.15B | |
| Weighted average by Cap. | -0.47% | +1.97% | +10.92% | +30.70% | +43.68% | +53.41% | +192.48% | +177.84% | +2,644.20% |
- Stock Market
- Stocks
- IVA Stock
- Sector Inventiva
Select your edition
All financial news and data tailored to specific country editions
